Literature DB >> 17956294

Chronic microglial activation and progressive dopaminergic neurotoxicity.

M L Block1, J-S Hong.   

Abstract

PD (Parkinson's disease) is characterized by the selective and progressive loss of DA neurons (dopaminergic neurons) in the substantia nigra. Inflammation and activation of microglia, the resident innate immune cell in the brain, have been strongly linked to neurodegenerative diseases, such as PD. Microglia can respond to immunological stimuli and neuronal death to produce a host of toxic factors, including cytokines and ROS (reactive oxygen species). Microglia can also become persistently activated after a single stimulus and maintain the elevated production of both cytokines and ROS, long after the instigating stimulus is gone. Current reports suggest that this chronic microglial activation may be fuelled by either dying/damaged neurons or autocrine and paracrine signals from local glial cells, such as cytokines. Here, we review proposed mechanisms responsible for chronic neuroinflammation and explain the interconnected relationship between deleterious microglial activation, DA neuron damage and neurodegenerative disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17956294     DOI: 10.1042/BST0351127

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  125 in total

1.  Chronic restraint stress triggers dopaminergic and noradrenergic neurodegeneration: Possible role of chronic stress in the onset of Parkinson's disease.

Authors:  Shuei Sugama; Kazunari Sekiyama; Tohru Kodama; Yoshiki Takamatsu; Takato Takenouchi; Makoto Hashimoto; Conti Bruno; Yoshihiko Kakinuma
Journal:  Brain Behav Immun       Date:  2015-08-17       Impact factor: 7.217

2.  Activated microglia decrease histone acetylation and Nrf2-inducible anti-oxidant defence in astrocytes: restoring effects of inhibitors of HDACs, p38 MAPK and GSK3β.

Authors:  Fernando Correa; Carina Mallard; Michael Nilsson; Mats Sandberg
Journal:  Neurobiol Dis       Date:  2011-07-02       Impact factor: 5.996

3.  The expression and release of Hsp60 in 6-OHDA induced in vivo and in vitro models of Parkinson's disease.

Authors:  Mei jiang Feng; Ling Zhang; Zhengxia Liu; Ping Zhou; Xiang Lu
Journal:  Neurochem Res       Date:  2013-08-14       Impact factor: 3.996

4.  Tinospora cordifolia Suppresses Neuroinflammation in Parkinsonian Mouse Model.

Authors:  Hareram Birla; Sachchida Nand Rai; Saumitra Sen Singh; Walia Zahra; Arun Rawat; Neeraj Tiwari; Rakesh K Singh; Abhishek Pathak; Surya Pratap Singh
Journal:  Neuromolecular Med       Date:  2019-01-14       Impact factor: 3.843

Review 5.  Parkinson's disease and enhanced inflammatory response.

Authors:  Iva Stojkovska; Brandon M Wagner; Brad E Morrison
Journal:  Exp Biol Med (Maywood)       Date:  2015-03-13

6.  The role of the immune system during regeneration of the central nervous system.

Authors:  K Z Sabin; K Echeverri
Journal:  J Immunol Regen Med       Date:  2019-11-05

7.  Oligomeric Aβ-induced microglial activation is possibly mediated by NADPH oxidase.

Authors:  Juan Li; Jing Yu Yang; Xue Chun Yao; Xue Xue; Qing Chun Zhang; Xiao Xiao Wang; Ling Ling Ding; Chun Fu Wu
Journal:  Neurochem Res       Date:  2012-12-11       Impact factor: 3.996

8.  Mechanisms underlying methamphetamine-induced dopamine transporter complex formation.

Authors:  Gregory C Hadlock; Anthony J Baucum; Jill L King; Kristen A Horner; Glen A Cook; James W Gibb; Diana G Wilkins; Glen R Hanson; Annette E Fleckenstein
Journal:  J Pharmacol Exp Ther       Date:  2009-01-13       Impact factor: 4.030

Review 9.  Molecular basis of etiological implications in Alzheimer's disease: focus on neuroinflammation.

Authors:  Rituraj Niranjan
Journal:  Mol Neurobiol       Date:  2013-02-19       Impact factor: 5.590

10.  NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administration.

Authors:  Liya Qin; Yuxin Liu; Jau-Shyong Hong; Fulton T Crews
Journal:  Glia       Date:  2013-03-28       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.